Nov 25, 2020
The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 3: Biologic Rationale for and Available Data with PARP Inhibition in Combination with Chemotherapeutic and Immunotherapeutic Agents in the Management of Advanced Ovarian Cancer — Dr Moore.
Nov 24, 2020
Featuring a discussion on recent data with CDK4/6 inhibitors in adjuvant therapy for ER-positive breast cancer with Prof Stephen Johnston, including the following topics:
Nov 23, 2020
Featuring a roundtable discussion with Drs Scott Kopetz, Wells A Messersmith and Alan P Venook on the following topics: